Australian biopharmaceutical research

View Our Work Latest News

Welcome to Servatus

We are an Australian biopharmaceuticals company, incorporated in 2012 and commencing operations in mid 2013. Servatus is focused on the development of effective treatments for chronic and inflammatory diseases - especially auto-immune diseases - utilising our proprietary technology. We are engineering "intelligent" directed changes into the structure of select proteins to improve their clinical utility.

We are also researching and engineering next generation live biotherapeutics for the treatment microbiome immune related conditions.

Learn more about us

Our Research Goals 

  • Commercialise our proprietary technology with one or more partners in the bio-pharmaceutical industry
  • Expand patent coverage to ensure broader protection of our core technology platform
  • Successfully complete clinical trials (human safety testing)

Latest News

See All News

Servatus Annual General Meeting

Notice of AGM Time & Place Notice is hereby given that an annual general meeting of Servatus Ltd ACN 160 435 254 will be held at the registered office, Innovation Centre, University of Sunshine Coast, 90 Sippy Downs Drive, Sippy Downs, Queensland 4556, at 11:00 (local time) on Saturday 27 October 2018.

Learn more

Scientific & Clinical advisory Panel appointments July 2018

Scientific & Clinical advisory Panel appointments

Learn more

Shareholder Bulletin July 2018

New Executive Director Appointed: Mark Williams

Learn more